Efficacy and Safety of Tralokinumab in US Adults With Moderate-to-Severe Atopic Dermatitis: A Post-Hoc Analysis of ECZTRA3. J of Skin 2023, 7 (2), 686-695. https://doi.org/10.25251/skin.7.2.5.